| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.81B | +55.0% |
| Gross Profit | $3.22B | +54.7% |
| R&D Expense | $1.95B | +9.8% |
| SG&A Expense | $1.83B | +21.7% |
| Operating Income | -$568.2M | +53.0% |
| Interest Expense | $46.9M | +125.5% |
| Pre-tax Income | -$533.0M | +35.5% |
| Income Tax | $111.8M | +100.1% |
| Net Income | -$644.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.63B | -17.2% |
| Accounts Receivable | $676.3M | +88.9% |
| Inventory | $495.0M | +19.0% |
| Current Assets | $3.99B | -5.0% |
| Total Assets | $5.92B | +2.0% |
| Current Liabilities | $2.21B | +22.4% |
| Long-term Debt | $166.5M | -15.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$140.6M | +87.8% |
| Capital Expenditures | $492.7M | -12.3% |
| Investing Cash Flow | -$548.4M | -1013.9% |
| Financing Cash Flow | $193.4M | -53.6% |
| Free Cash Flow | -$633.3M | +63.2% |
| +26.9% |
| EPS (Basic) | -$0.47 | +27.7% |
| EPS (Diluted) | -$0.47 | +27.7% |
| Total Liabilities |
| $2.59B |
| +14.1% |
| Stockholders' Equity | $3.33B | -5.8% |